Consensus Hangzhou Tigermed Consulting Co., Ltd

Equities

300347

CNE100001KV8

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 25/04/2024 BST			5-day change	1st Jan Change
57.7 ^CNY	+8.85%		+16.24%	+4.97%

04-25	Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	MT
04-25	Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	CI

Evolution of the average Target Price on Hangzhou Tigermed Consulting Co., Ltd

Price target over the last 5 years

History of analyst recommendation changes

91d7640add589.7E-T0nOapRxE2pruYH0Gsxl95uT9u96Z3Xo50IDzF1w.ghfnlx_F73g0vs7dMQRshFUulbOrz-3Rqwly57O7IWmhKcPlKq_CTnCY8Q~05071ea947a7bc91a7a24c61adae044b

Analyst Recommendations on Hangzhou Tigermed Consulting Co., Ltd

Nomura Downgrades Hangzhou Tigermed Consulting to Neutral From Buy, Adjusts Price Target to 49.61 Yuan From 75.72 Yuan	03-05	MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$32.69 From HK$57.77	03-05	MT
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to 75.72 Yuan from 83.50 Yuan, Keeps at Buy	30/10/23	MT
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to HK$57.77 from HK$64.46, Keeps at Buy	30/10/23	MT
Nomura Adjusts Tigermed to Buy From Neutral, Adjusts Price Target to 83.50 Yuan From 91.67 Yuan	24/07/23	MT
Nomura Upgrades Tigermed to Buy From Neutral, Adjusts Price Target to HK$64.46 From HK$79.47	24/07/23	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 91.67 Yuan From 118.38 Yuan, Keeps at Neutral	26/04/23	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$79.47 From HK$102.23, Keeps at Neutral	26/04/23	MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$102.23 From HK$80.36	16/02/23	MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to 118.38 Yuan From 116.32 Yuan	16/02/23	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$80.36 From HK$105.58, Keeps at Buy	26/10/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 116.32 Yuan From 119.66 Yuan, Keeps at Buy	26/10/22	MT
UBS Adjusts Hangzhou Tigermed Consulting's Price Target to 147.28 Yuan From 154.78 Yuan, Keeps at Buy	30/08/22	MT
UBS Adjusts Hangzhou Tigermed Consulting's Price Target to HK$126.22 From HK$138.82, Keeps at Buy	30/08/22	MT
Nomura Adjusts Tigermed’s Price Target to HK$105.58 From HK$108.33, Keeps at Buy	26/08/22	MT
Nomura Adjusts Tigermed’s Price Target to 122.78 Yuan From 119.66 Yuan, Nomura Keeps at Buy	26/08/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 122.78 Yuan From 125.87 Yuan, Keeps at Buy	02/08/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$108.33 From HK$115.13, Keeps at Buy	02/08/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$115.13 From HK$134.75, Keeps at Buy	27/04/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 125.87 Yuan From 147.33 Yuan, Keeps at Buy	27/04/22	MT
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$134.75 From HK$141.67, Keeps at Buy	14/03/22	MT
Nomura Adjusts Tigermed's Price Target to 147.33 Yuan From 154.89 Yuan, Keeps at Buy	14/03/22	MT